bioRxiv · 10.1101/2024.05.19.594874
Human birth tissue products as a regenerative medicine to inhibit post-surgical pain through multi-modal action
Abstract
Pain after surgery causes significant suffering. Opioid analgesics cause severe side effects and accidental death. Therefore, there is an urgent need to develop non-opioid therapies for managing post-surgical pain. Local application of Clarix Flo (FLO), a human amniotic membrane (AM) product, attenuated established post-surgical pain hypersensitivity without exhibiting known side effects of opioid use in mice. This effect was achieved through direct inhibition of nociceptive dorsal root ganglion (DRG) neurons via CD44-dependent pathways. We further purified the major matrix component, the heavy chain-hyaluronic acid/pentraxin 3 (HC-HA/PTX3) from human AM that has greater purity and water solubility than FLO. HC-HA/PTX3 replicated FLO-induced neuronal and pain inhibition. Mechanistically, HC-HA/PTX3 induced cytoskeleton rearrangements to inhibit sodium current and high-voltage activated calcium current on nociceptive neurons, suggesting it is a key bioactive component mediating pain relief. Collectively, our findings highlight the potential of naturally derived biologics from human birth tissues as an effective non-opioid treatment for post-surgical pain. Moreover, we unravel the underlying mechanisms of pain inhibition induced by FLO and HC-HA/PTX3.
Source connections
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Zhang, C., Huang, Q., Ford, N. C., Limjunyawong, N., Lin, Q., Yang, F., Cui, X., Uniyal, A., Liu, J., Mahabole, M., He, H., Wang, X., Duff, I., Wang, Y., Wan, J., Zhu, G., Raja, S. N., Jia, H., Yang, D., Dong, X., Tseng, S., He, S., Guan, Y.. 2024-05-20. Human birth tissue products as a regenerative medicine to inhibit post-surgical pain through multi-modal action. https://doi.org/10.1101/2024.05.19.594874
Cite the original work for its findings. Save a collection to share your selection of sources.